Home/Filings/4/0001764013-23-000045
4//SEC Filing

Fromkin Andrew J. 4

Accession 0001764013-23-000045

CIK 0001764013other

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 4:33 PM ET

Size

7.4 KB

Accession

0001764013-23-000045

Insider Transaction Report

Form 4
Period: 2023-04-12
Transactions
  • Award

    Common Stock

    2023-04-12+12,523101,008 total
  • Award

    Stock Option (right to buy)

    2023-04-12+16,26016,260 total
    Exercise: $14.70Exp: 2033-04-12Common Stock (16,260 underlying)
Footnotes (3)
  • [F1]Represents the number of shares underlying restricted stock units awards ("RSUs").
  • [F2]The RSUs vest in their entirety one year after the date of grant on April 12, 2024, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
  • [F3]The shares underlying the options vest one year after the date of grant on April 12, 2024, subject to the Reporting Person's continuous service to the Issuer as of such date.

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001341896

Filing Metadata

Form type
4
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:33 PM ET
Size
7.4 KB